Fracture liaison service model: treatment persistence 5 years later
- PMID: 33813663
- DOI: 10.1007/s11657-021-00925-6
Fracture liaison service model: treatment persistence 5 years later
Abstract
We analyzed the long-term persistence of treatment in a FLS. During follow-up, 15.2% of patients had a refracture and 23.8% died. At the 5-year checkup, 74% had started treatment (associated with female sex, previous use of bisphosphonate, and referral to an osteoporosis clinic). Persistence at 1 and 5 years was 70.6% and 46.5%, respectively.
Introduction: To analyze the long-term persistence of treatment in a fracture liaison service (FLS).
Methods: Patients ≥ 50 years with a fragility fracture attended between 2012 and 2016 who were recommended for treatment to prevent new fractures were included. Baseline data included demographics, type of fracture, previous treatment, and FRAX® items. Five years later, patient records were reviewed and the following data were collected: [1] survival; [2] refracture; [3] initiation of treatment, persistence, and medication possession ratio (MPR) > 80%.
Results: We included 888 patients, mean age 75 years, 83% women, and mean follow-up 56 months. During follow-up, 135 patients (15.2%) had a refracture (109 major fractures, 50 hip refractures) and 212 patients died (23.8%); at the 5-year checkup, 657 patients (74%) had started some type of treatment. Factors associated with the start of treatment were female sex (OR 2.10; 95% CI: 1.42-3.11), previous use of bisphosphonate (OR 3.91; 95% CI: 2.23-6.86), and referral to an osteoporosis clinic (OR 1.46; 95% CI: 1.02-2.07). Persistence decreased from 70.6% at 12 months to 46.5% at 60 months. An MPR > 80% was confirmed in 449 patients, 68.3% of whom were under treatment. A total of 521 and 447 patients received treatment for at least 24 and 36 months, respectively (79.3% and 68.0% of those who started treatment).
Conclusions: Patients with fragility fractures attended at an FLS showed optimal long-term persistence of treatment. These data can help healthcare managers better calculate the cost-effectiveness of implementing the FLS model.
Keywords: Adherence; Bisphosphonate; Fracture; Fracture liaison service; Osteoporosis; Persistence.
References
-
- Wu CH, Tu ST, Chang YF, Chan DC, Chien JT, Lin CH, Singh S, Dasari M, Chen JF, Tsai KS (2018) Fracture liaison services improve outcomes of patients with osteoporosis-related fractures: a systematic literature review and meta-analysis. Bone. 111:92–100. https://doi.org/10.1016/j.bone.2018.03.018 - DOI - PubMed
-
- Naranjo A, Ojeda-Bruno S, Bilbao-Cantarero A, Quevedo-Abeledo JC, Diaz-González BV, Rodríguez-Lozano C (2015) Two-year adherence to treatment and associated factors in a fracture liaison service in Spain. Osteoporos Int 26(11):2579–2585. https://doi.org/10.1007/s00198-015-3185-z - DOI - PubMed
-
- Chandran M, Cheen M, Ying H, Lau TC, Tan M (2016) Dropping the ball and falling off the care wagon. Factors Correlating With Nonadherence to Secondary Fracture Prevention Programs J Clin Densitom 19:117–124. https://doi.org/10.1016/j.jocd.2015.06.009 - DOI - PubMed
-
- Senay A, Fernandes JC, Delisle J, Morin SN, Perreault S (2019) Persistence and compliance to osteoporosis therapy in a fracture liaison service: a prospective cohort study. Arch Osteoporos 14(1):87. Published 2019 Aug 3. https://doi.org/10.1007/s11657-019-0633-y - DOI - PubMed
-
- Scholten DJ 2nd, Bray JK, Wang KY, Lake AF, Emory CL (2020) Implementation of a fracture liaison service and its effects on osteoporosis treatment adherence and secondary fracture at a tertiary care academic health system. Arch Osteoporos 15(1):80. Published 2020 May 28. https://doi.org/10.1007/s11657-020-00736-1 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
